Intranigral dynorphin-1-13 suppresses kindled seizures by a naloxone-insensitive mechanism
- 28 February 1987
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 405 (2) , 358-363
- https://doi.org/10.1016/0006-8993(87)90306-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Changes in dynorphin, enkephalin and cholecystokinin content of hippocampus and substantia nigra after amygdala kindlingBrain Research, 1986
- Effect of intranigral injections of dynorphin, dynorphin fragments and α-neoendorphin on rotational behaviour in the ratEuropean Journal of Pharmacology, 1984
- Intranigral muscimol suppresses ethanol withdrawal seizuresBrain Research, 1984
- Lesions of substantia nigra protect against experimentally induced seizuresBrain Research, 1983
- Substantia Nigra: Site of Anticonvulsant Activity Mediated by γ-Aminobutyric AcidScience, 1982
- Dynorphin Is a Specific Endogenous Ligand of the κ Opioid ReceptorScience, 1982
- Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexusNature, 1981
- Behavioral effects and in vivo degradation of intraventricularly administered dynorphin-(1-13) and D-Ala2-dynorphin-(1-11) in ratsLife Sciences, 1980
- A permanent change in brain function resulting from daily electrical stimulationExperimental Neurology, 1969
- Development of Epileptic Seizures through Brain Stimulation at Low IntensityNature, 1967